Coherus BioSciences (CHRS) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free CHRS Stock Alerts $1.93 -0.09 (-4.46%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Coherus BioSciences Stock Price Performance5 Day Performance-6.76%1 Month Performance-16.09%3 Month Performance-17.52%6 Month Performance-29.56%Year-To-Date Performance-42.04%1 Year Performance-74.30% Receive CHRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Preserve GoldTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?Click here to get your complimentary retirement guide! CHRS Stock Chart for Friday, April, 26, 2024 CHRS Chart by TradingView Coherus BioSciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$2.02$1.93-4.46%$2.02$1.912.22 million shs$219.06 million04/24/2024$2.18$2.02-7.34%$2.21$2.02718,918 shs$229.27 million04/23/2024$2.18$2.18$2.25$2.10811,789 shs$247.43 million04/22/2024$2.07$2.18+5.31%$2.19$2.041.50 million shs$247.43 million04/19/2024$2.00$2.07+3.50%$2.09$1.952.88 million shs$234.94 million04/18/2024$2.15$2.00-6.98%$2.19$1.991.91 million shs$227 million Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$2.15$2.15$2.22$2.121.26 million shs$242.33 million04/16/2024$2.20$2.15-2.27%$2.20$2.121.37 million shs$242.33 million04/15/2024$2.23$2.20-1.35%$2.24$2.142.20 million shs$247.96 million04/12/2024$2.41$2.23-7.47%$2.43$2.202.02 million shs$251.34 million04/11/2024$2.45$2.41-1.63%$2.52$2.331.76 million shs$271.63 million04/10/2024$2.47$2.45-0.81%$2.46$2.311.63 million shs$276.14 million04/09/2024$2.51$2.47-1.59%$2.61$2.461.44 million shs$278.39 million04/08/2024$2.43$2.51+3.29%$2.55$2.442.11 million shs$282.90 million04/05/2024$2.33$2.43+4.29%$2.48$2.251.47 million shs$273.89 million04/04/2024$2.38$2.33-2.10%$2.45$2.301.50 million shs$262.61 million04/03/2024$2.36$2.38+0.85%$2.49$2.302.69 million shs$268.25 million04/02/2024$2.40$2.36-1.67%$2.37$2.271.53 million shs$266.00 million04/01/2024$2.39$2.40+0.42%$2.42$2.301.77 million shs$270.50 million03/29/2024$2.39$2.39$2.51$2.362.10 million shs$269.38 million03/28/2024$2.42$2.39-1.24%$2.51$2.362.09 million shs$269.38 million03/27/2024$2.30$2.42+5.22%$2.44$2.282.58 million shs$272.76 million03/26/2024$2.28$2.30+0.88%$2.39$2.294.94 million shs$259.23 million03/25/2024$2.33$2.28-2.15%$2.40$2.261.92 million shs$256.98 million03/22/2024$2.51$2.33-7.17%$2.49$2.322.08 million shs$262.61 million03/21/2024$2.48$2.51+1.21%$2.64$2.473.27 million shs$282.90 million03/20/2024$2.45$2.48+1.22%$2.55$2.353.86 million shs$279.53 million03/19/2024$2.22$2.45+10.36%$2.48$2.183.41 million shs$272.83 million03/18/2024$2.22$2.22$2.26$2.142.54 million shs$247.22 million03/15/2024$2.17$2.22+2.30%$2.28$2.173.53 million shs$247.23 million03/14/2024$2.30$2.17-5.65%$2.55$2.056.16 million shs$241.65 million03/13/2024$2.24$2.30+2.68%$2.38$2.173.01 million shs$256.13 million03/12/2024$2.27$2.24-1.32%$2.36$2.222.21 million shs$249.45 million03/11/2024$2.39$2.27-5.02%$2.45$2.241.90 million shs$252.79 million03/08/2024$2.21$2.39+8.14%$2.55$2.234.92 million shs$266.15 million03/07/2024$2.21$2.21$2.24$2.133.02 million shs$246.11 million03/06/2024$2.18$2.21+1.38%$2.32$2.191.89 million shs$246.11 million03/05/2024$2.27$2.18-3.96%$2.25$2.152.08 million shs$242.77 million03/04/2024$2.41$2.27-5.81%$2.54$2.253.09 million shs$252.79 million03/01/2024$2.28$2.41+5.70%$2.47$2.272.29 million shs$268.39 millionTrump is sounding the alarm (Ad)Europe is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?Click here to get your complimentary retirement guide!02/29/2024$2.36$2.28-3.39%$2.44$2.263.68 million shs$253.90 million02/28/2024$2.62$2.36-9.92%$2.59$2.353.11 million shs$262.81 million02/27/2024$2.50$2.62+4.80%$2.63$2.472.75 million shs$291.76 million02/26/2024$2.58$2.50-3.10%$2.65$2.432.56 million shs$278.40 million02/23/2024$2.47$2.58+4.45%$2.60$2.421.90 million shs$287.31 million02/22/2024$2.48$2.47-0.40%$2.54$2.421.98 million shs$275.06 million02/21/2024$2.59$2.48-4.25%$2.57$2.421.71 million shs$276.17 million02/20/2024$2.76$2.59-6.16%$2.78$2.591.83 million shs$288.42 million02/19/2024$2.76$2.76$2.85$2.731.88 million shs$307.35 million02/16/2024$2.85$2.76-3.16%$2.85$2.731.87 million shs$307.35 million02/15/2024$2.72$2.85+4.78%$2.87$2.682.87 million shs$317.38 million02/14/2024$2.56$2.72+6.25%$2.72$2.561.75 million shs$302.90 million02/13/2024$2.82$2.56-9.22%$2.69$2.502.91 million shs$285.08 million02/12/2024$2.62$2.82+7.63%$2.84$2.573.25 million shs$314.04 million02/09/2024$2.38$2.62+10.08%$2.66$2.354.11 million shs$291.76 million02/08/2024$2.32$2.38+2.59%$2.39$2.252.31 million shs$265.04 million02/07/2024$2.32$2.32$2.34$2.225.22 million shs$258.36 million02/06/2024$2.02$2.32+14.85%$2.33$1.974.25 million shs$258.36 million02/05/2024$2.06$2.02-1.94%$2.08$1.933.49 million shs$224.95 million02/02/2024$2.09$2.06-1.44%$2.10$1.933.98 million shs$229.40 million02/01/2024$2.15$2.09-2.79%$2.21$2.083.47 million shs$232.75 million01/31/2024$2.31$2.15-6.93%$2.34$2.154.23 million shs$239.42 million01/30/2024$2.30$2.31+0.43%$2.33$2.176.77 million shs$257.24 million01/29/2024$2.34$2.30-1.71%$2.38$2.244.23 million shs$256.13 million01/26/2024$2.37$2.34-1.27%$2.40$2.311.62 million shs$260.58 million01/25/2024$2.30$2.37+3.04%$2.41$2.233.57 million shs$263.92 million Related Companies: Adverum Biotechnologies Stock Price Chart Sutro Biopharma Stock Price Chart X4 Pharmaceuticals Stock Price Chart Compass Therapeutics Stock Price Chart Elevation Oncology Stock Price Chart Acumen Pharmaceuticals Stock Price Chart Innate Pharma Stock Price Chart Opthea Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Black Diamond Therapeutics Stock Price Chart Receive CHRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CHRS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.